Abstract
Mesenchymal stem cells (MSCs) have pointed as a promising alternative for cellular therapy because of the large capacity of self-regeneration, low immunogenicity, paracrine, anti-inflammatory, immunomodulatory and antiapoptotic effects. Important properties such as low immunogenicity and absence of reactions observed in allogeneic implants with MSCs, are features that corroborate for the …